找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Drug Development in Psychiatry; Matthew Macaluso,Sheldon H. Preskorn,Richard C. Sh Book 2023 The Editor(s) (if applicable) and The Author(

[复制链接]
查看: 16772|回复: 58
发表于 2025-3-21 17:50:42 | 显示全部楼层 |阅读模式
书目名称Drug Development in Psychiatry
编辑Matthew Macaluso,Sheldon H. Preskorn,Richard C. Sh
视频video
概述Reviews critical elements of both basic and clinical science as they pertain to drug development in psychiatry.It covers both historical elements and modern interpretations to understand best practice
丛书名称Advances in Neurobiology
图书封面Titlebook: Drug Development in Psychiatry;  Matthew Macaluso,Sheldon H. Preskorn,Richard C. Sh Book 2023 The Editor(s) (if applicable) and The Author(
描述.The book reviews clinical trial methodology as it pertains to drug development in psychiatry. The reader will understand the process of drug development in psychiatry from discovery through marketing with the help of clinically relevant examples. The reader will appreciate the history of drug development in psychiatry dating back to the era of serendipitous discovery and culminating in an era of new and highly focused targets. Readers will understand how drug development in psychiatry has changed and adapted with the discovery of novel mechanism of action drugs. Novel drugs and disease targets have changed the way developers and regulatory agencies think about clinical trial methodology..The book elucidates how biomarkers, genetics and advances in neuroscience and neuroimaging have influenced drug development approaches, which will ultimately change the practice of psychiatry. The book will be broken down into the following sections:.a.        Prior to the 1960s - Drug discovery by chance observation.b.       The last 50 years – refined targeting of CNS drugs without the discovery of mechanistically new drugs.c.       The future – the discovery and development of mechanistically n
出版日期Book 2023
关键词clinical trial; SPECT; APOE4; fMRI; florbetapir; biomarkers; clinical psychiatry; psychiatric medications
版次1
doihttps://doi.org/10.1007/978-3-031-21054-9
isbn_softcover978-3-031-21056-3
isbn_ebook978-3-031-21054-9Series ISSN 2190-5215 Series E-ISSN 2190-5223
issn_series 2190-5215
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

书目名称Drug Development in Psychiatry影响因子(影响力)




书目名称Drug Development in Psychiatry影响因子(影响力)学科排名




书目名称Drug Development in Psychiatry网络公开度




书目名称Drug Development in Psychiatry网络公开度学科排名




书目名称Drug Development in Psychiatry被引频次




书目名称Drug Development in Psychiatry被引频次学科排名




书目名称Drug Development in Psychiatry年度引用




书目名称Drug Development in Psychiatry年度引用学科排名




书目名称Drug Development in Psychiatry读者反馈




书目名称Drug Development in Psychiatry读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:54:29 | 显示全部楼层
发表于 2025-3-22 01:26:41 | 显示全部楼层
发表于 2025-3-22 05:47:41 | 显示全部楼层
https://doi.org/10.1007/978-3-663-11765-0velopment, it is important to first understand the history of psychiatry including early attempts at drug discovery and develoment. The early history of psychiatry is mired with the use of inhumane experimental treatments and the institutionalization of patients in asylums. Some of the earliest drug
发表于 2025-3-22 11:26:36 | 显示全部楼层
Integrationstheorie und Mehrebenenpolitik,al models have been essential in the in vivo validation of novel drug targets, establishment of lead compound pharmacokinetic to pharmacodynamic relationships, optimization of lead compounds through preclinical candidate selection, and development of translational measures of target occupancy and fu
发表于 2025-3-22 16:34:47 | 显示全部楼层
Grundkonzepte der Programmierung and neurodegenerative disorders such as depression, ADHD, neuropathic pain, anxiety disorders, stimulant use disorders, epilepsy, and Parkinson’s disease. The MAT family is comprised of three main members – the dopamine transporter (DAT), the norepinephrine transporter (NET), and the serotonin tran
发表于 2025-3-22 18:55:46 | 显示全部楼层
发表于 2025-3-22 22:17:18 | 显示全部楼层
Grundkonzepte der Programmierunghic and comorbid clinical characteristics. Is this medicine more effective, safe, tolerable, or affordable than the options used in the past? A payer may ask if the new medication offers a more effective, cost-efficient, or convenient alternative to those treatments already being covered. These are
发表于 2025-3-23 03:53:59 | 显示全部楼层
Objektorientierte Programmierungrom investments diverted to other therapeutic areas to reduced reliance on efficacy claims derived from preclinical models. In this chapter, we argue that there are several existing examples that teach us on what needs to be done to improve the success rate. We advocate the reverse engineering appro
发表于 2025-3-23 07:23:27 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-15 13:57
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表